Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Marijuana (cannabis) has been used in patients with Acquired Immune Deficiency Syndrome (AIDS) primarily to alleviate symptoms such as nausea, loss of appetite, and chronic pain associated with the disease and its treatments. Scientific studies, including randomized controlled trials, have demonstrated that cannabinoids—the active compounds in marijuana—can stimulate appetite and reduce nausea in HIV/AIDS patients. For instance, dronabinol, an FDA-approved synthetic form of THC (the main psychoactive component of cannabis), is prescribed to manage anorexia and weight loss in AIDS patients. Clinical evidence shows modest efficacy in appetite stimulation and weight gain compared to placebo. Some studies also suggest potential benefits for neuropathic pain related to HIV/AIDS.

However, the evidence is not robust across all symptoms, and marijuana is not considered a primary treatment for HIV/AIDS itself but rather as an adjunct for symptom management. Side effects such as cognitive impairment and potential for substance misuse are also considerations in its use. Overall, the use of marijuana for symptom relief in AIDS patients is supported by moderate-quality scientific evidence, particularly for appetite and weight loss management, but is not curative for the underlying disease or immune dysfunction.

More about Marijuana
More about Acquired Immune Deficiency Syndrome

Other ingredients used for Acquired Immune Deficiency Syndrome

Other health conditions supported by Marijuana

Products containing Marijuana